ConductScience.org, home

Paper769722

Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms.

Janowsky DS and 1 other. Arch Gen Psychiatry, 1976. Cited by 189 papers, by iCite.

Cite this record

ConductScience Library. Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. Papers, record 769722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/769722

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms.
PubMed
Journal
Arch Gen Psychiatry
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
189
iCite
Relative citation ratio, by iCite
8.9
iCite
Revised in PubMed
2019-07-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Janowsky DSD S
2Davis JMJ M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmphetaminesMajor topic
DextroamphetamineMajor topic
MethylphenidateMajor topic
SchizophreniaMajor topic
Schizophrenic PsychologyMajor topic
Acute Disease
Clinical Trials as Topic
Humans
Levodopa

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 189 citations.

PMIDTitleJournalYearIn PapersSource
26485338Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study.J Clin Psychopharmacol2015https://conductscience.org/library/papers/26485338PubMed
24494093Reporting a Case of Injecting Methylphenidate (Ritalin) Tablets, Intensified Symptoms of Schizoph-renia or Induce Separate Mental Disorder?Addict Health2009https://conductscience.org/library/papers/24494093PubMed
21199449Dopamine receptor homooligomers and heterooligomers in schizophrenia.CNS Neurosci Ther2011https://conductscience.org/library/papers/21199449PubMed
19051222Evolution of stimulants to treat ADHD: transdermal methylphenidate.Hum Psychopharmacol2009https://conductscience.org/library/papers/19051222PubMed
17519393Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?Schizophr Bull2007https://conductscience.org/library/papers/17519393PubMed
17080442Methylphenidate-induced activation of the anterior cingulate but not the striatum: a [15O]H2O PET study in healthy volunteers.Hum Brain Mapp2007https://conductscience.org/library/papers/17080442PubMed
16220327Assessment of methylphenidate-induced changes in binding of continuously infused [(11)C]-raclopride in healthy human subjects: correlation with subjective effects.Psychopharmacology (Berl)2005https://conductscience.org/library/papers/16220327PubMed
15707502Khat use as risk factor for psychotic disorders: a cross-sectional and case-control study in Somalia.BMC Med2005https://conductscience.org/library/papers/15707502PubMed
15495131Amphetamines for schizophrenia.Cochrane Database Syst Rev2004https://conductscience.org/library/papers/15495131PubMed
12601500The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.Psychopharmacology (Berl)2003https://conductscience.org/library/papers/12601500PubMed
12003681Cannabis and psychosis.Curr Psychiatry Rep2002https://conductscience.org/library/papers/12003681PubMed
11707061Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.Clin Pharmacokinet2001https://conductscience.org/library/papers/11707061PubMed
10107491Myths and mystifications of managed care.J Ment Health Adm1990https://conductscience.org/library/papers/10107491PubMed
9502830Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine.J Neurosci1998https://conductscience.org/library/papers/9502830PubMed
8619004Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence.Psychopharmacology (Berl)1995https://conductscience.org/library/papers/8619004PubMed
7870913Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations.Psychopharmacology (Berl)1993https://conductscience.org/library/papers/7870913PubMed
6785807Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6785807PubMed
6425912Hypersensitivity to d-amphetamine several years after early social deprivation in rhesus monkeys.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6425912PubMed
6137773Pathophysiology of schizophrenia - causal role for dopamine or noradrenaline?Nature1983https://conductscience.org/library/papers/6137773PubMed
6129159The biology of schizophrenia.Experientia1982https://conductscience.org/library/papers/6129159PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/769722

GET https://conductscience.org/api/papers/v1/769722/cited_by?page=2